<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02321423</url>
  </required_header>
  <id_info>
    <org_study_id>20040468</org_study_id>
    <nct_id>NCT02321423</nct_id>
  </id_info>
  <brief_title>International Pachyonychia Congenita Research Registry</brief_title>
  <acronym>IPCRR</acronym>
  <official_title>International Pachyonychia Congenita Research Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pachyonychia Congenita Project</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pachyonychia Congenita Project</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      International Pachyonychia Congenita Research Registry (IPCRR) is a patient registry for
      those suffering from Pachyonychia Congenita (PC). PC is an ultra-rare extremely painful skin
      disorder that causes painful blisters and callus on feet and sometimes hands, thickened
      nails, cysts and other features. The IPCRR consists of a questionnaire, patient photos,
      optional physician notes from telephone consultation to validate questionnaire and free
      genetic testing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HOW TO PARTICIPATE IN IPCRR

      Step One: The IPCRR forms are available online at
      http://www.pachyonychia.org/patient-registry/. The Consent Form protects your privacy and the
      Questionnaire gathers important details that distinguish PC from other conditions and helps
      to identify specific characteristics of each type of PC. You may stop and start as often as
      needed before completing the forms. If you are not certain about an answer, you may skip that
      question.

      Step Two: Take photos as shown in the Questionnaire sample photo page. You can upload the
      images online with the Questionnaire. If you prefer, you may email the photos. Photos of your
      PC are very important. Note: If you do not have access to a computer and wish to have the
      IPCRR forms mailed, please contact PC Project.

      Step Three: When your Consent Form, Questionnaire, and Photos are received by PC Project, we
      will have an intake call with you to review your information and to discuss the next steps.

      Step Four: If referred for genetic testing, you will then be sent the special saliva test kit
      (no travel required). Usually, only saliva is needed and from only one family member. The
      sample is collected by spitting into the vial in the kit and then mailing it in the envelope
      provided. Genetic testing is complex and time-consuming â€” it is not like a sugar test or
      pregnancy test, and can take many months to be completed, but the testing begins as soon as
      your sample arrives.

      When the confirming results are received, a full genetic testing report is provided to you
      with precise information and suggestions specific to your condition. You may find the report
      very valuable with physicians or other medical providers as well as for school personnel,
      employers, disability hearings, or other special needs. All information is held
      confidentially by PC Project and the research is reported anonymously. There is no cost to
      you for any of these tests or assistance from PC Project. You may also request additional
      consultations as needed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Describing patterns and traits of Pachyonychia Congenita</measure>
    <time_frame>Once a year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Pachyonychia Congenita</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All persons with PC in all countries are being invited to register. It is not known how
        many persons have PC although it is known to be a very rare disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Pachyonychia Congenita or similar disorder

        Exclusion Criteria:

          -  N/A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C. David Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pachyonychia Congenita Project</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Holly A Evans</last_name>
    <phone>8019878758</phone>
    <email>holly.evans@pachyonychia.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janice N Schwartz</last_name>
    <phone>8019878758</phone>
    <email>jan.schwartz@pachyonychia.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pachyonychia Congenita Project</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Schwartz</last_name>
      <phone>801-987-8758</phone>
      <email>jan.schwartz@pachyonychia.org</email>
    </contact>
    <contact_backup>
      <last_name>Holly Evans</last_name>
      <phone>8019878758</phone>
      <email>holly.evans@pachyonychia.org</email>
    </contact_backup>
    <investigator>
      <last_name>C. David Hansen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pachyonychia.org</url>
    <description>Pachyonychia Congenita Project Website</description>
  </link>
  <link>
    <url>http://www.pachyonychia.org/patient-registry/</url>
    <description>Link to IPCRR information and forms</description>
  </link>
  <link>
    <url>http://www.pachyonychia.org/pc-data/</url>
    <description>Link to data/graphs from IPCRR</description>
  </link>
  <link>
    <url>http://www.pachyonychia.org/research-articles/</url>
    <description>Link to Published Research Articles on PC</description>
  </link>
  <reference>
    <citation>Wilson NJ, O'Toole EA, Milstone LM, Hansen CD, Shepherd AA, Al-Asadi E, Schwartz ME, McLean WH, Sprecher E, Smith FJ. The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol. 2014 Aug;171(2):343-55. doi: 10.1111/bjd.12958. Epub 2014 Aug 6.</citation>
    <PMID>24611874</PMID>
  </reference>
  <reference>
    <citation>Shah S, Boen M, Kenner-Bell B, Schwartz M, Rademaker A, Paller AS. Pachyonychia congenita in pediatric patients: natural history, features, and impact. JAMA Dermatol. 2014 Feb;150(2):146-53. doi: 10.1001/jamadermatol.2013.6448.</citation>
    <PMID>24132595</PMID>
  </reference>
  <results_reference>
    <citation>McLean WH, Hansen CD, Eliason MJ, Smith FJ. The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol. 2011 May;131(5):1015-7. doi: 10.1038/jid.2011.59. Epub 2011 Mar 24. Review.</citation>
    <PMID>21430705</PMID>
  </results_reference>
  <results_reference>
    <citation>Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol. 2012 Oct;67(4):680-6. doi: 10.1016/j.jaad.2011.12.009. Epub 2012 Jan 20.</citation>
    <PMID>22264670</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2014</study_first_posted>
  <last_update_submitted>November 19, 2018</last_update_submitted>
  <last_update_submitted_qc>November 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nail Dystrophy</keyword>
  <keyword>Plantar Keratoderma</keyword>
  <keyword>Palmar Keratoderma</keyword>
  <keyword>Leukokeratosis</keyword>
  <keyword>Cysts</keyword>
  <keyword>Pain</keyword>
  <keyword>KRT17</keyword>
  <keyword>KRT16</keyword>
  <keyword>KRT6A</keyword>
  <keyword>KRT6B</keyword>
  <keyword>KRT6C</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pachyonychia Congenita</mesh_term>
    <mesh_term>Nails, Malformed</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

